An Appeals court has overturned a lower court ruling that found Medtronic (MDT +0.2%) did not infringe on Boston Scientific (BSX -1.4%) CRT patents, and has remanded the case for further proceedings. The appeals court says the lower court relied on a "legally incorrect allocation of the burden of proof" and incorrectly construed the claim terms in the suit.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Thu, 2:30PM)
at Zacks.com (Feb 26, 2015)
at Zacks.com (Feb 24, 2015)
UPDATE: Medtronic plc: FDA Approves the VenaSeal Closure System for Treatment of Clinically Symptomatic Venous Refluxat Benzinga.com (Feb 24, 2015)
at Zacks.com (Feb 23, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs